Hinen A Series: Pioneering Safety Standards at All Energy Australia 2024
MELBOURNE, Australia, Oct. 24, 2024 (GLOBE NEWSWIRE) -- As the renewable energy sector surges, the need for safe and reliable home energy storage solutions becomes paramount. At All Energy Australia…
Form 8.3 – [KEYWORDS STUDIOS PLC – 22 10 2024]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
MKS Instruments Breaks Ground on Super Center Factory in Malaysia
ANDOVER, Mass., United States and KUALA LUMPUR, Malaysia, Oct. 24, 2024 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that transform the world, the Malaysian…
Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC – 22 10 2024]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Share Buyback Transaction Details October 17 – October 23, 2024
PRESS RELEASE Share Buyback Transaction Details October 17 – October 23, 2024 Alphen aan den Rijn – October 24, 2024 - Wolters Kluwer (Euronext: WKL), a global leader in professional…
Lumos Pharma Enters into Definitive Merger Agreement with Double Point Ventures to Go Private via a Tender Offer of $4.25 Cash per Share Plus Contingent Value Rights (CVR)
AUSTIN, Texas, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO) (“Lumos Pharma” or the “Company”), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today…
Optical Transceiver Market to Register 11.5% by 2031
Westford,USA, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Optical Transceiver Market size was valued at USD 10.82 billion in 2022 and is poised to grow from USD 12.06 billion in 2023 to USD 28.82 billion by 2031,…
Vistin Pharma ASA: Invitation to Q3 2024 conference call
Oslo, Norway, 24 October 2024 Vistin Pharma ASA will release its third quarter and YTD 2024 results on Thursday 31st of October 2024. Vistin Pharma will host a conference call…
Presentation Nilörn Interim Report Q3, 2024
A presentation will be held via Teams 25/10 at 08.30 am CET, where the CEO presents the report. You can participate by register on the link below: Registration Form For…
Presentation Delårsrapport Q3, 2024
En presentation kommer hållas via Teams 25/10 kl. 08.30, där VD presenterar rapporten. Du kan delta genom att registrera dig på nedanstående länk: Registration Form För ytterligare information om Nilörn,…